

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.54780113 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.10879332 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.95953619 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.95953619 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.79775658 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.46331410 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.43509417 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.39648450 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.36383167 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.08727634 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.04398881 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.04398881 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.04398881 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.04398881 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.04398881 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.04398881 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.00635954 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.94900091 |
| 19 | detection of other organism (GO:0098543) | 3.82666293 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 3.82396948 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.81099606 |
| 22 | detection of bacterium (GO:0016045) | 3.69583069 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 3.63457028 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.60976733 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.56109422 |
| 26 | cellular extravasation (GO:0045123) | 3.49755527 |
| 27 | microglial cell activation (GO:0001774) | 3.46939520 |
| 28 | negative thymic T cell selection (GO:0045060) | 3.38942798 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.37430398 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.34395400 |
| 31 | muscle filament sliding (GO:0030049) | 3.34300044 |
| 32 | actin-myosin filament sliding (GO:0033275) | 3.34300044 |
| 33 | negative T cell selection (GO:0043383) | 3.32934431 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.28025250 |
| 35 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27557233 |
| 36 | regulation of relaxation of muscle (GO:1901077) | 3.23698578 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.23578067 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.21877167 |
| 39 | response to peptidoglycan (GO:0032494) | 3.21702744 |
| 40 | response to interleukin-15 (GO:0070672) | 3.17595798 |
| 41 | positive T cell selection (GO:0043368) | 3.16735491 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.12641238 |
| 43 | detection of molecule of bacterial origin (GO:0032490) | 3.08515174 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.04892476 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.04892476 |
| 46 | response to type I interferon (GO:0034340) | 3.04450462 |
| 47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01735292 |
| 48 | response to host immune response (GO:0052572) | 2.98773661 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98773661 |
| 50 | response to interferon-beta (GO:0035456) | 2.98713220 |
| 51 | cellular response to interleukin-15 (GO:0071350) | 2.98040751 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97286853 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 2.95115810 |
| 54 | positive regulation of granulocyte differentiation (GO:0030854) | 2.93468571 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 2.93459648 |
| 56 | leukocyte aggregation (GO:0070486) | 2.93158959 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 2.93038409 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 2.90051794 |
| 59 | regulation of germinal center formation (GO:0002634) | 2.89886875 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89433001 |
| 61 | B cell mediated immunity (GO:0019724) | 2.88210572 |
| 62 | macrophage activation (GO:0042116) | 2.84437559 |
| 63 | neutrophil activation (GO:0042119) | 2.83812178 |
| 64 | germinal center formation (GO:0002467) | 2.83774097 |
| 65 | regulation of mast cell activation (GO:0033003) | 2.81924703 |
| 66 | detection of biotic stimulus (GO:0009595) | 2.81032003 |
| 67 | response to muramyl dipeptide (GO:0032495) | 2.79598146 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77554518 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77506701 |
| 70 | T cell selection (GO:0045058) | 2.77410875 |
| 71 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75585721 |
| 72 | positive regulation of mast cell degranulation (GO:0043306) | 2.75585721 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.75472800 |
| 74 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75335136 |
| 75 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73561236 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73504808 |
| 77 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.72744612 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71834653 |
| 79 | T cell migration (GO:0072678) | 2.70400865 |
| 80 | cytidine metabolic process (GO:0046087) | 2.70289041 |
| 81 | cytidine catabolic process (GO:0006216) | 2.70289041 |
| 82 | cytidine deamination (GO:0009972) | 2.70289041 |
| 83 | negative regulation of innate immune response (GO:0045824) | 2.68645366 |
| 84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.68280538 |
| 85 | respiratory burst (GO:0045730) | 2.68066505 |
| 86 | regulation of necroptotic process (GO:0060544) | 2.66440526 |
| 87 | leukocyte degranulation (GO:0043299) | 2.66093189 |
| 88 | regulation of skeletal muscle contraction (GO:0014819) | 2.66020971 |
| 89 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.64822695 |
| 90 | thymic T cell selection (GO:0045061) | 2.64147188 |
| 91 | mast cell activation (GO:0045576) | 2.64137691 |
| 92 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63791916 |
| 93 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.61821986 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.61769506 |
| 95 | response to host (GO:0075136) | 2.61769506 |
| 96 | response to host defenses (GO:0052200) | 2.61769506 |
| 97 | regulation of granulocyte differentiation (GO:0030852) | 2.60841884 |
| 98 | creatine metabolic process (GO:0006600) | 2.60283410 |
| 99 | neutrophil mediated immunity (GO:0002446) | 2.59621687 |
| 100 | regulation of tolerance induction (GO:0002643) | 2.59015002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32420325 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.91952923 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.74265319 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.53383524 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.06525899 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.94121408 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84837149 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82558887 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.78194937 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44356984 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.39946865 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.37925600 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36197725 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32311101 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.15866792 |
| 16 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.13815585 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98942437 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98233803 |
| 19 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.92256630 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91532420 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.89156295 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80262880 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78600093 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 1.75337674 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74747700 |
| 26 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.73752670 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70756721 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68751556 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67868974 |
| 30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67167173 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63249552 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61440252 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58987078 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58885780 |
| 35 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56545151 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56363669 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55373221 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.52269357 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51053135 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45376672 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42801746 |
| 42 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40238551 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34628605 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33726344 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.32837738 |
| 46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32559319 |
| 47 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29581876 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27520611 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27240908 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24431368 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23562559 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22805826 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20252058 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20097996 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17458935 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16215014 |
| 57 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.15366810 |
| 58 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15043843 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11522387 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10745741 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09413781 |
| 62 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08752908 |
| 63 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08704091 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08510887 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06619106 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04919529 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04423571 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04217429 |
| 69 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02697087 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02216347 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00512181 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99263524 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98007394 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97500745 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96188317 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 0.95664460 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95070427 |
| 78 | * P300_27268052_Chip-Seq_Bcells_Human | 0.95003147 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94602578 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94128699 |
| 81 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92953426 |
| 82 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89941838 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89704882 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89541019 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88996906 |
| 86 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88274735 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88247516 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88032763 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87720605 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86742218 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86404313 |
| 92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86342270 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83456009 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82845585 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82435652 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82007144 |
| 97 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81866827 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81708259 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81157499 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81157499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.77737015 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.26119039 |
| 3 | MP0003646_muscle_fatigue | 2.98798147 |
| 4 | MP0003436_decreased_susceptibility_to | 2.89780918 |
| 5 | MP0003303_peritoneal_inflammation | 2.54785879 |
| 6 | MP0005671_abnormal_response_to | 2.52296907 |
| 7 | MP0001800_abnormal_humoral_immune | 2.45755169 |
| 8 | MP0002419_abnormal_innate_immunity | 2.38013432 |
| 9 | MP0005025_abnormal_response_to | 2.31042651 |
| 10 | MP0005387_immune_system_phenotype | 2.27392431 |
| 11 | MP0001790_abnormal_immune_system | 2.27392431 |
| 12 | MP0000685_abnormal_immune_system | 2.26214387 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.22358153 |
| 14 | MP0009785_altered_susceptibility_to | 2.22257181 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.14304015 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.11353468 |
| 17 | MP0002723_abnormal_immune_serum | 2.11181426 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.05806534 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.05549137 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.04916072 |
| 21 | MP0003828_pulmonary_edema | 2.03004090 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.01833384 |
| 23 | MP0001819_abnormal_immune_cell | 2.01461810 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.93304289 |
| 25 | MP0005451_abnormal_body_composition | 1.82335135 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.81067871 |
| 27 | MP0004130_abnormal_muscle_cell | 1.79258462 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.76756201 |
| 29 | MP0000751_myopathy | 1.74614685 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.67815046 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.67186542 |
| 32 | MP0006082_CNS_inflammation | 1.60503333 |
| 33 | MP0002405_respiratory_system_inflammati | 1.55776142 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.55733187 |
| 35 | MP0009278_abnormal_bone_marrow | 1.55190068 |
| 36 | MP0000716_abnormal_immune_system | 1.53038287 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.51843804 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.51136366 |
| 39 | MP0002398_abnormal_bone_marrow | 1.51124975 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.50052240 |
| 41 | MP0000749_muscle_degeneration | 1.49301443 |
| 42 | MP0009764_decreased_sensitivity_to | 1.49028281 |
| 43 | MP0002132_abnormal_respiratory_system | 1.46158627 |
| 44 | MP0004510_myositis | 1.45904109 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.42094543 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.41983362 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.41983362 |
| 48 | MP0008260_abnormal_autophagy | 1.39732823 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.38901162 |
| 50 | MP0004484_altered_response_of | 1.38622454 |
| 51 | MP0005330_cardiomyopathy | 1.34499833 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.33069624 |
| 53 | MP0003075_altered_response_to | 1.32363497 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.31535752 |
| 55 | MP0004215_abnormal_myocardial_fiber | 1.30198653 |
| 56 | MP0003866_abnormal_defecation | 1.26671445 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.25948251 |
| 58 | MP0002722_abnormal_immune_system | 1.23602712 |
| 59 | MP0008469_abnormal_protein_level | 1.21468726 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.17318893 |
| 61 | MP0002429_abnormal_blood_cell | 1.17255419 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.17182399 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.12670207 |
| 64 | MP0002106_abnormal_muscle_physiology | 1.12160229 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.11740992 |
| 66 | MP0003690_abnormal_glial_cell | 1.10623841 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.08480303 |
| 68 | MP0002972_abnormal_cardiac_muscle | 1.08279436 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 1.07700337 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.04834265 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.01520107 |
| 72 | MP0003045_fibrosis | 0.99684821 |
| 73 | MP0004087_abnormal_muscle_fiber | 0.99631853 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 0.99283003 |
| 75 | MP0005166_decreased_susceptibility_to | 0.98367147 |
| 76 | MP0002269_muscular_atrophy | 0.97422138 |
| 77 | MP0005620_abnormal_muscle_contractility | 0.96874461 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.95354338 |
| 79 | MP0000343_altered_response_to | 0.95227415 |
| 80 | MP0008004_abnormal_stomach_pH | 0.95216188 |
| 81 | MP0001851_eye_inflammation | 0.95144575 |
| 82 | MP0004947_skin_inflammation | 0.94668321 |
| 83 | MP0005670_abnormal_white_adipose | 0.93875706 |
| 84 | MP0000604_amyloidosis | 0.93825867 |
| 85 | MP0005385_cardiovascular_system_phenoty | 0.91067164 |
| 86 | MP0001544_abnormal_cardiovascular_syste | 0.91067164 |
| 87 | MP0000747_muscle_weakness | 0.89602552 |
| 88 | MP0002933_joint_inflammation | 0.85832820 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.84466690 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.84390179 |
| 91 | MP0005266_abnormal_metabolism | 0.84269426 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 0.84259799 |
| 93 | MP0009763_increased_sensitivity_to | 0.81822692 |
| 94 | MP0001853_heart_inflammation | 0.81811777 |
| 95 | MP0005535_abnormal_body_temperature | 0.81379775 |
| 96 | MP0005369_muscle_phenotype | 0.81011032 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.78992401 |
| 98 | MP0006138_congestive_heart_failure | 0.77748883 |
| 99 | MP0000759_abnormal_skeletal_muscle | 0.76255822 |
| 100 | MP0004883_abnormal_blood_vessel | 0.75929092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36373853 |
| 2 | Myositis (HP:0100614) | 4.30958394 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.08228269 |
| 4 | Exercise-induced myalgia (HP:0003738) | 3.86403108 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.85609737 |
| 6 | Orchitis (HP:0100796) | 3.83573965 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.70917718 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.69111288 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.66658557 |
| 10 | Stomatitis (HP:0010280) | 3.66220255 |
| 11 | Nemaline bodies (HP:0003798) | 3.65197545 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.61339608 |
| 13 | Optic neuritis (HP:0100653) | 3.61339608 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.54879365 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.51732986 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.50987276 |
| 17 | Meningitis (HP:0001287) | 3.30886550 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.25711474 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.18862372 |
| 20 | Sudden death (HP:0001699) | 3.16367948 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16047304 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16047304 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.11125142 |
| 24 | Chest pain (HP:0100749) | 3.10661868 |
| 25 | Agammaglobulinemia (HP:0004432) | 2.99806301 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.96635993 |
| 27 | Obstructive lung disease (HP:0006536) | 2.96102784 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96102784 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 2.93596057 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 2.84516121 |
| 31 | Recurrent skin infections (HP:0001581) | 2.81014010 |
| 32 | Rhabdomyolysis (HP:0003201) | 2.81012601 |
| 33 | Encephalitis (HP:0002383) | 2.80437107 |
| 34 | Vasculitis (HP:0002633) | 2.77353615 |
| 35 | EMG: myopathic abnormalities (HP:0003458) | 2.77082202 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 2.75344968 |
| 37 | Granulocytopenia (HP:0001913) | 2.69589145 |
| 38 | Prolonged bleeding time (HP:0003010) | 2.63847871 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.63373963 |
| 40 | Exercise-induced muscle cramps (HP:0003710) | 2.60966439 |
| 41 | Hemoptysis (HP:0002105) | 2.59660603 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.55998176 |
| 43 | Myoglobinuria (HP:0002913) | 2.53728629 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.52552078 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.51266442 |
| 46 | Abnormality of T cells (HP:0002843) | 2.50677291 |
| 47 | Increased IgE level (HP:0003212) | 2.48893825 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.45409609 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.45202959 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.44463989 |
| 51 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.42978937 |
| 52 | Type 1 muscle fiber predominance (HP:0003803) | 2.42111739 |
| 53 | T lymphocytopenia (HP:0005403) | 2.41954655 |
| 54 | Leukocytosis (HP:0001974) | 2.41878661 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.37336681 |
| 56 | Eosinophilia (HP:0001880) | 2.36778676 |
| 57 | Arterial thrombosis (HP:0004420) | 2.35091723 |
| 58 | Difficulty running (HP:0009046) | 2.34923125 |
| 59 | Bundle branch block (HP:0011710) | 2.34287485 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.33386241 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.32998182 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.32797657 |
| 63 | Cellulitis (HP:0100658) | 2.30258565 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.29275015 |
| 65 | Epistaxis (HP:0000421) | 2.28172231 |
| 66 | Calf muscle hypertrophy (HP:0008981) | 2.26284032 |
| 67 | Urticaria (HP:0001025) | 2.26119311 |
| 68 | Neck muscle weakness (HP:0000467) | 2.22385641 |
| 69 | Ragged-red muscle fibers (HP:0003200) | 2.18101372 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.18016380 |
| 71 | Increased IgM level (HP:0003496) | 2.17234600 |
| 72 | Recurrent viral infections (HP:0004429) | 2.16924871 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.16433855 |
| 74 | Gingival bleeding (HP:0000225) | 2.14908215 |
| 75 | Myopathic facies (HP:0002058) | 2.14480594 |
| 76 | Abnormality of the endocardium (HP:0004306) | 2.11373695 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.11203180 |
| 78 | Pulmonary embolism (HP:0002204) | 2.11140223 |
| 79 | Vertigo (HP:0002321) | 2.09322218 |
| 80 | Gingivitis (HP:0000230) | 2.09275752 |
| 81 | Colitis (HP:0002583) | 2.08949812 |
| 82 | Abnormality of the prostate (HP:0008775) | 2.08765416 |
| 83 | Ventricular arrhythmia (HP:0004308) | 2.08294985 |
| 84 | Stomach cancer (HP:0012126) | 2.03968748 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.01195998 |
| 86 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.98506111 |
| 87 | Ventricular fibrillation (HP:0001663) | 1.97640308 |
| 88 | Recurrent bronchitis (HP:0002837) | 1.97082709 |
| 89 | Severe combined immunodeficiency (HP:0004430) | 1.96293508 |
| 90 | Syncope (HP:0001279) | 1.95488807 |
| 91 | EMG: neuropathic changes (HP:0003445) | 1.95252960 |
| 92 | Frequent falls (HP:0002359) | 1.94541527 |
| 93 | Facial diplegia (HP:0001349) | 1.94482306 |
| 94 | Hypochromic anemia (HP:0001931) | 1.94058314 |
| 95 | Areflexia of lower limbs (HP:0002522) | 1.91942490 |
| 96 | Petechiae (HP:0000967) | 1.89790714 |
| 97 | Distal arthrogryposis (HP:0005684) | 1.89782551 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89349720 |
| 99 | Acute hepatic failure (HP:0006554) | 1.89239717 |
| 100 | Amyloidosis (HP:0011034) | 1.88840143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.27639949 |
| 2 | OBSCN | 3.23802856 |
| 3 | RIPK4 | 3.21824164 |
| 4 | FES | 2.86041544 |
| 5 | TAOK3 | 2.54864686 |
| 6 | TXK | 2.38964847 |
| 7 | KIT | 2.38158724 |
| 8 | ERN1 | 2.36603682 |
| 9 | BLK | 2.34854929 |
| 10 | MAP2K3 | 2.33684283 |
| 11 | TYK2 | 2.22966663 |
| 12 | BCKDK | 2.02691067 |
| 13 | TNK2 | 1.97346652 |
| 14 | SYK | 1.90705742 |
| 15 | GRK6 | 1.72922620 |
| 16 | BTK | 1.72521899 |
| 17 | JAK3 | 1.65024364 |
| 18 | ZAP70 | 1.64226666 |
| 19 | TBK1 | 1.63474642 |
| 20 | TEC | 1.61959778 |
| 21 | CSK | 1.61658619 |
| 22 | TTN | 1.61013726 |
| 23 | TIE1 | 1.59296535 |
| 24 | ITK | 1.54739411 |
| 25 | PIK3CG | 1.51205220 |
| 26 | CSF1R | 1.48154071 |
| 27 | IKBKE | 1.47867949 |
| 28 | PHKG1 | 1.46346669 |
| 29 | PHKG2 | 1.46346669 |
| 30 | MAPK12 | 1.46241863 |
| 31 | IRAK4 | 1.44637474 |
| 32 | MAP3K11 | 1.43549620 |
| 33 | HCK | 1.41555778 |
| 34 | EPHB1 | 1.37524274 |
| 35 | MAP3K7 | 1.23744679 |
| 36 | LYN | 1.22927530 |
| 37 | MAP3K13 | 1.17284441 |
| 38 | JAK1 | 1.16841045 |
| 39 | PINK1 | 1.16608564 |
| 40 | LCK | 1.16104570 |
| 41 | JAK2 | 1.15290959 |
| 42 | DAPK2 | 1.13614940 |
| 43 | TESK2 | 1.10827286 |
| 44 | FRK | 1.10729077 |
| 45 | MAP3K14 | 1.07121195 |
| 46 | CDK19 | 1.04846733 |
| 47 | MAP3K3 | 0.96668301 |
| 48 | KDR | 0.96426385 |
| 49 | IKBKB | 0.89098789 |
| 50 | PRPF4B | 0.88244225 |
| 51 | MAP3K1 | 0.87893309 |
| 52 | GRK7 | 0.84959111 |
| 53 | MAP2K6 | 0.84849113 |
| 54 | PDK1 | 0.84613311 |
| 55 | TGFBR2 | 0.83433320 |
| 56 | PRKCQ | 0.81821352 |
| 57 | MAPK7 | 0.80700205 |
| 58 | CDC42BPA | 0.79445694 |
| 59 | PTK2B | 0.74419616 |
| 60 | MAP3K5 | 0.73793931 |
| 61 | PRKAA2 | 0.68898917 |
| 62 | MARK2 | 0.68711615 |
| 63 | BMPR2 | 0.68166842 |
| 64 | EPHA3 | 0.65754791 |
| 65 | TAOK1 | 0.64094174 |
| 66 | PRKD1 | 0.63205367 |
| 67 | MARK3 | 0.60999735 |
| 68 | PIK3CA | 0.60552738 |
| 69 | MUSK | 0.58713777 |
| 70 | MATK | 0.58329640 |
| 71 | FGR | 0.58076046 |
| 72 | MAPKAPK3 | 0.57607031 |
| 73 | GRK5 | 0.57496757 |
| 74 | MAPK11 | 0.55940804 |
| 75 | TRPM7 | 0.53096120 |
| 76 | STK11 | 0.52720624 |
| 77 | PDPK1 | 0.50910612 |
| 78 | MAP4K2 | 0.48800497 |
| 79 | MAPK4 | 0.48769845 |
| 80 | OXSR1 | 0.48602360 |
| 81 | FYN | 0.48469003 |
| 82 | SIK2 | 0.48013623 |
| 83 | NLK | 0.47287052 |
| 84 | FGFR3 | 0.46520916 |
| 85 | MAP2K4 | 0.45360153 |
| 86 | IRAK1 | 0.45272953 |
| 87 | TLK1 | 0.44777741 |
| 88 | CAMK1 | 0.44448945 |
| 89 | HIPK2 | 0.43946834 |
| 90 | PIM1 | 0.42859841 |
| 91 | CAMK4 | 0.42042208 |
| 92 | TAOK2 | 0.41287794 |
| 93 | MAP3K6 | 0.41035951 |
| 94 | SGK2 | 0.39688242 |
| 95 | MAPK13 | 0.39463606 |
| 96 | RAF1 | 0.39140265 |
| 97 | RPS6KC1 | 0.39083478 |
| 98 | RPS6KL1 | 0.39083478 |
| 99 | RPS6KA6 | 0.38955397 |
| 100 | LRRK2 | 0.38378992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.28138639 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.18017305 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.17817955 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.11752831 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.09124941 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88736669 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.76140615 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.52384927 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.41989058 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39656378 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22799169 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.04318645 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96422111 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.86675173 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.77624209 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.75959311 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.73118451 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70234791 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35968984 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35712407 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34876520 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32080311 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28683724 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27235706 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26782474 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.20544145 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.19696616 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16024941 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.14619750 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12335052 |
| 31 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.10554752 |
| 32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.09942967 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.08486959 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07186426 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04273918 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03639348 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01258657 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95322787 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93776545 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93389249 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92836559 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90965524 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88340919 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87760909 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.86641486 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83173149 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.80824283 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76380136 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76317404 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74922686 |
| 51 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74793077 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.74463301 |
| 53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.72501921 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68414013 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67983441 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67300006 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.66714973 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.66446050 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65814161 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65388013 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65248394 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64875414 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64172808 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63807463 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61798261 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58229303 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57737113 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57605466 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.56861400 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.55296346 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54881591 |
| 72 | Renin secretion_Homo sapiens_hsa04924 | 0.54030426 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53868348 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53709435 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51781332 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50541490 |
| 77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49305588 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48164198 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.47818192 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45410445 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43127835 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38536772 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38477994 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.36087182 |
| 85 | Salivary secretion_Homo sapiens_hsa04970 | 0.35742592 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35136610 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34799184 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33226187 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33103118 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33085685 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.30980647 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30039695 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29887162 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29745532 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29323756 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28564804 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27734381 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25743680 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24446256 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24170103 |

